Singh Biotechnology, LLC
At a glance
EmployeesNot reported
In business since2014
HeadquartersLutz, FL
US patents4
SAM.gov UEIQ4FARYHRKRM5
CAGE code7DMR9
Incorporated inFL
Supplier designations
For Profit OrganizationMinority Owned BusinessWoman Owned BusinessWoman Owned Small Business
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2019–2024, 2 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Therapeutics directed against coronavirusUS 11,951,174 · granted APR 9, 2024
- Single domain antibodies directed against arachidonate 12-lipoxygenaseUS 11,214,626 · granted JAN 4, 2022
- Single domain antibodies directed against ebola virus VP24US 10,369,223 · granted AUG 6, 2019
- Single domain antibodies directed against human immunodeficiency virusUS 10,195,277 · granted FEB 5, 2019
Granted to Singh Biotechnology, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Singh Biotechnology, LLC | Lutz | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.